Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11267818 Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

Patent 11267818 was granted and assigned to Array Biopharma Inc. on March, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Array Biopharma Inc.

Current Assignee

Array Biopharma Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

March 8, 2022

Patent Application Number

17020461

Date Filed

September 14, 2020

Patent Citations

US Patent 10137127 Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide

US Patent 10005783 Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

US Patent 10011604 Method of treatment using substituted imidazo[1,2b]pyridazine compounds

US Patent 10047097 Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

US Patent 10172861 Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate

Patent Primary Examiner

Patent abstract

Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11267818 Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool